Form 4: NHC Senior VP & CIO Granted 14,000 Stock Options

National Healthcare Corp's Senior VP & CIO, Ben Anderson Flatt Sr., was granted 14,000 stock options under the 2020 Omnibus Equity Incentive Plan.

Summary

• Ben Anderson Flatt Sr., Senior VP & CIO of National Healthcare Corp (NHC), reported changes in beneficial ownership.
• He was granted 14,000 stock options on February 23, 2026, with an exercise price of $157.13.
• These newly granted options will vest ratably over three years, with one-third vesting on February 23, 2027, another third on February 23, 2028, and the final third on February 23, 2029.
• The newly granted options expire on February 24, 2031.
• This grant was made under the 2020 Omnibus Equity Incentive Plan and is exempt from Section 16(b) pursuant to Rule 16b-3(d).
• Flatt Sr. also beneficially owns 14,117.0547 shares of common stock directly.
• He holds additional stock options from previous grants: 7,467 options at $53.94 (expiring March 8, 2028), 12,000 options at $94.1 (expiring March 5, 2029), and 13,500 options at $90.62 (expiring February 24, 2030).

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, reflecting continued executive alignment with shareholder interests through equity incentives, which is a standard and healthy corporate governance practice.

Positives

• The grant of 14,000 stock options to a Senior VP & CIO aligns management incentives with shareholder value.
• The three-year ratable vesting schedule encourages long-term commitment and performance from the executive.

Future Outlook

The vesting schedule for the newly granted stock options extends through February 23, 2029, indicating a long-term incentive structure for the Senior VP & CIO, aligning executive interests with future company performance.

Industry Context

StockSavvy.ai notes that executive stock option grants are a common practice in the healthcare industry, aligning executive incentives with long-term company performance and shareholder value. Such grants are standard components of executive compensation packages designed to retain key talent and motivate strategic growth.

Comparison to Industry Standards

• The grant of 14,000 stock options to a Senior VP & CIO is a typical component of executive compensation in publicly traded healthcare companies, comparable to practices at peers like HCA Healthcare or Universal Health Services, where equity incentives are used to reward performance and ensure executive retention.
• The three-year ratable vesting schedule is a common industry standard, promoting sustained performance over short-term gains, similar to vesting schedules observed in companies like Tenet Healthcare or Community Health Systems.

Corporate Governance

Related Party Transactions

• The filing details an insider transaction involving the grant of stock options to a Senior VP & CIO, which is a form of related party dealing as part of executive compensation.

Stakeholder Impact

• Shareholders: Potential positive impact due to increased alignment of executive incentives with long-term company performance.
• Management: The Senior VP & CIO receives additional equity incentives, potentially increasing motivation and retention.

Next Steps

• One-third of the 14,000 stock options will vest on February 23, 2027.
• Another one-third of the 14,000 stock options will vest on February 23, 2028.
• The final one-third of the 14,000 stock options will vest on February 23, 2029.

Key Dates

Recommendation

This Form 4 filing reports a routine executive stock option grant, which is an expected part of compensation and does not typically indicate a significant change in the company's fundamental outlook or operations. While it shows continued alignment of executive interests, it's not a catalyst for a 'buy' or 'sell' recommendation on its own. Therefore, a 'hold' recommendation is appropriate as it maintains the current position based on existing company fundamentals.

Keywords

National Healthcare Corp, NHC, stock options, insider transaction, Form 4, equity incentive plan, executive compensation, beneficial ownership